Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

TTM Technologies Inc. Appoints Dr. Edwin Roks as New CEO

TTM Technologies, Inc. has announced the appointment of Edwin Roks, Ph.D., as its new President and Chief Executive Officer, effective September 2nd, 2025. Dr. Roks succeeds Thomas T. Edman, who has been the company's CEO since 2014 and is set to retire. Mr. Edman will continue to serve on the board and the government security committee beyond January 1, 2026.

Dr. Roks most recently served as CEO of Teledyne Technologies Incorporated until April 2025, where he was instrumental in expanding the company's capabilities across critical markets, including aerospace & defense, industrial, and communications. TTM Technologies' Chairman, Rex Geveden, expressed excitement at welcoming Dr. Roks, highlighting his proven leadership, deep industry knowledge, strong technical and operational expertise, and strategic vision.

During Dr. Roks' tenure at Teledyne, he contributed to the growth in the digital imaging area, the advancement of technology across their business portfolio, and the successful integration of Teledyne's largest acquisitions. Dr. Roks has expressed his honor in joining TTM Technologies at such an exciting time and looks forward to working with the talented team to deliver continued value to customers, shareholders, and employees.

Mr. Edman, the outgoing CEO, expressed confidence in the company's future under Dr. Roks' leadership, citing his global experience, technical depth, and commitment to excellence.

TTM Technologies, Inc. is a leading global manufacturer of technology solutions, including mission systems, RF components, RF microwave/microelectronic assemblies, and quick-turn and technologically advanced PCBs. Following these announcements, the company's shares moved -3.58%, and are now trading at a price of $44.96. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS